Metadherin, the breast cancer gene linke...
New Brunswick, N.J., January 5, 2009 – A team of researchers at Princeton University and The Cancer Institute of New Jersey (CINJ) has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The gene, called
Stand Up To Cancer Telethon
www.standup2cancer.org is the web address where you can donate to stand up to cancer. The historic telethon that airs September 5 is a momentous event that hopes to bring national attention to the importance of cancer research and hoping to touch the next level - finding a cure for cancer.
Interesting
Categories
Archives
Subscribe to the RSS